Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Benita

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Drug Metabolism|September 7, 2011
The ligand nanoparticle conjugation approach for targeted cancer therapyNour Karra, Simon Benita
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 7, 2004
The potential of lipid emulsion for ocular delivery of lipophilic drugsShunmugaperumal Tamilvanan, Simon Benita
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2004
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsR Neslihan Gursoy, Simon Benita
Journal of Drug Targeting|December 13, 2006
Non-systemic delivery of topical brimonidine to the brain: a neuro-ocular tissue distribution studyMuhammad Abdulrazik, Shunmugaperumal Tamilvanan, Simon Benita
Critical Reviews in Therapeutic Drug Carrier Systems|January 27, 2009
Nanoparticle-cell interactions: drug delivery implicationsOshrat Harush-Frenkel, Yoram Altschuler, Simon Benita
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 18, 2008
Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticlesNir Debotton, Marcela Parnes, Jean Kadouche, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 30, 2008
Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drugTaher Nassar, Alona Rom, Abraham Nyska, et al.
Cancer Research|January 11, 2007
Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancerDanny Goldstein, Ofer Gofrit, Abraham Nyska, et al.
Pharmaceutical Research|June 27, 2008
A novel nanocapsule delivery system to overcome intestinal degradation and drug transport limited absorption of P-glycoprotein substrate drugsTaher Nassar, Alona Rom, Abraham Nyska, et al.
Biochemical and Biophysical Research Communications|December 23, 2006
Targeting of nanoparticles to the clathrin-mediated endocytic pathwayOshrat Harush-Frenkel, Nir Debotton, Simon Benita, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Drug Metabolism|September 7, 2011
The ligand nanoparticle conjugation approach for targeted cancer therapyNour Karra, Simon Benita
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 7, 2004
The potential of lipid emulsion for ocular delivery of lipophilic drugsShunmugaperumal Tamilvanan, Simon Benita
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 15, 2004
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugsR Neslihan Gursoy, Simon Benita
Journal of Drug Targeting|December 13, 2006
Non-systemic delivery of topical brimonidine to the brain: a neuro-ocular tissue distribution studyMuhammad Abdulrazik, Shunmugaperumal Tamilvanan, Simon Benita
Critical Reviews in Therapeutic Drug Carrier Systems|January 27, 2009
Nanoparticle-cell interactions: drug delivery implicationsOshrat Harush-Frenkel, Yoram Altschuler, Simon Benita
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 18, 2008
Overcoming the formulation obstacles towards targeted chemotherapy: in vitro and in vivo evaluation of cytotoxic drug loaded immunonanoparticlesNir Debotton, Marcela Parnes, Jean Kadouche, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 30, 2008
Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drugTaher Nassar, Alona Rom, Abraham Nyska, et al.
Cancer Research|January 11, 2007
Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancerDanny Goldstein, Ofer Gofrit, Abraham Nyska, et al.
Pharmaceutical Research|June 27, 2008
A novel nanocapsule delivery system to overcome intestinal degradation and drug transport limited absorption of P-glycoprotein substrate drugsTaher Nassar, Alona Rom, Abraham Nyska, et al.
Biochemical and Biophysical Research Communications|December 23, 2006
Targeting of nanoparticles to the clathrin-mediated endocytic pathwayOshrat Harush-Frenkel, Nir Debotton, Simon Benita, et al.
Pageof 5